1.0Division of Infectious Diseases/medicine/infdisgsa/medicine/infdis/author/gsa/rich600338<blockquote class="wp-embedded-content" data-secret="ECmEvj5q3N"><a href="/medicine/infdis/people/david-van-duin-md-phd/">David van Duin, MD, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/medicine/infdis/people/david-van-duin-md-phd/embed/#?secret=ECmEvj5q3N" width="600" height="338" title="“David van Duin, MD, PhD” — Division of Infectious Diseases" data-secret="ECmEvj5q3N" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> /medicine/infdis/wp-content/uploads/sites/1276/2023/03/DvD_2018_5-scaled.jpg20782560Dr. van Duin is the founding Director of the Immunocompromised Host ID service. His main research interests are multi-drug resistant Gram-negative bacteria, and infections in immunocompromised patients. He is the PI for the MDRO Network of the Antibacterial Resistance Leadership Group. Within the MDRO Network, the consortium on resistance against carbapenems in Klebsiella and other … Read more